Buy price
262.62
AbbVie Inc. (ABBV) Stock Price Today — Live Chart and Analysis
Skyrizi and Rinvoq are growing fast enough to offset Humira biosimilar erosion. Botox revenue came via the 2020 Allergan acquisition. Dividend raised for 52 consecutive years.
Sell price
262.43
Market Cap
119.76 B
AbbVie Inc. chart
Price Performance
Information regarding past performance is not a reliable indicator of future performance.
AbbVie Inc. ABBV Profile
- Sector Health Care
- Industry Biotechnology
- Country United States
- Founded 2013
- ISIN US00287Y1091
- CEO Robert Michael
- abbvie.com
Analysis
Q2 2026 net revenues were $16.99 billion, up 10.2%. Adjusted EPS of $3.65 grew 22.9%. Skyrizi and Rinvoq grew 24%. Apogee Therapeutics acquisition announced for $10.9 billion. Full-year adjusted EPS guidance $13.87–$14.07. Dividend yield 3.2%.
How can I buy AbbVie Inc.?
- 1
Sign up
Create an account and complete a quick verification.
- 2
Deposit funds
Add money to your wallet via card, bank transfer, or crypto.
- 3
Trade
Choose ABBV, set the amount, and click buy or sell — that’s it!
AbbVie Inc.
ABBV
262.525
Instrument CFD
FAQ